Clinical Trial

A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study is a randomized, double-Blind, placebo-controlled, Single- and Multiple-ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Clinical Activity of BBT002 in Healthy Volunteers and Participants with Chronic Obstructive Pulmonary Disease (COPD).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-12-16; most recent amendment 2026-07-21.
Trial Details
NCT Number NCT07288554
Lead Sponsor Bambusa Therapeutics
Conditions Chronic Obstructive Pulmonary Disease (COPD)
Enrollment 68 participants
Start Date 2025-09-05
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-05-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-22